Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study
Paul M. Ridker(Brigham and Women's Hospital), Daniel I. Chasman(Brigham and Women's Hospital), Jacqueline Suk Danik(Brigham and Women's Hospital), Guillaume Paré(Impact), Joseph P. Miletich(Washington University in St. Louis), Nancy R. Cook(Brigham and Women's Hospital), Julie E. Buring(Brigham and Women's Hospital), Robert Y.L. Zee(Brigham and Women's Hospital), David J. Kwiatkowski(Brigham and Women's Hospital), Alex Parker(Amgen (United States))
Cited by 348
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k